Vol 72, No 2 (2021)
Clinical vignette
Published online: 2021-01-19
Severe hypophosphataemic osteomalacia related to low-dose adefovir dipivoxil therapy in a hepatitis B virus patient
Abstract
Not required for Clinical Vignette.
Keywords: hypophosphataemic osteomalaciaadefovir dipivoxilchronic hepatitis B
References
- Leowattana W. Antiviral Drugs and Acute Kidney Injury (AKI). Infect Disord Drug Targets. 2019; 19(4): 375–382.
- Izzedine H, Hulot JS, Launay-Vacher V, et al. Adefovir Dipivoxil International 437 Study Group, Adefovir Dipivoxil International 438 Study Group. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int. 2004; 66(3): 1153–1158.
- Park S, Kim WI, Cho DH, et al. Adefovir-induced Fanconi syndrome associated with osteomalacia. Clin Mol Hepatol. 2017; 24(3): 339–344.
- Lv Y, Li X, Liang S, et al. The clinical and pathological features of adefovir dipivoxil-related renal impairment . Clin Nephrol. 2019; 91(3): 180–186.
